ABBOTT LABORATORIES — Director's Dealing 2020

Oct 5, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2020-10-01

Reporting Person: Ahlberg Gregory A (Senior Vice President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	6526	Direct
Common shares without par value	10596	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$48.98	2027-08-13	Common shares (6000)		Direct
Option (right to buy)	$59.94	2028-02-15	Common shares (46403)		Direct
Option (right to buy)	$75.90	2029-02-21	Commons shares (38190)		Direct
Option (right to buy)	$87.72	2030-02-20	Common shares (32244)		Direct

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of October 1, 2020.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 5,334 on August 14, 2018, 5,333 on August 14, 2019 and 5,333 on August 14, 2020.

F3: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,468 on February 16, 2019, 15,467 on February 16, 2020 and 15,468 on February 16, 2021.

F4: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,730 on each of February 22, 2020, February 22, 2021 and February 22, 2022.

F5: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,748 on each of February 21, 2021, February 21, 2022 and February 21, 2023.